Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hemopexin
- Development stage
- Phase 2
- Lead developer
- CSL Behring
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
Hemopexin is a plasma glycoprotein with the highest binding affinity for free heme in humans. It acts as a scavenger of free heme released during hemolysis, thereby preventing the pro-oxidant and pro-inflammatory effects of free heme and promoting its detoxification. By binding to free heme, hemopexin forms a complex that is cleared by receptors such as LRP1 on hepatocytes or macrophages in the liver, spleen, and bone marrow. This mechanism protects tissues from oxidative damage and inflammation associated with hemolytic conditions. Therapeutically, exogenous administration of hemopexin has shown promise in preclinical models for protecting against vascular dysfunction and organ damage in diseases characterized by excessive hemolysis, such as sickle cell disease and β-thalassemia[2][4][6].
- Other names
- beta-1B-glycoproteinbeta1B-glycoproteinbeta 1B-glycoproteinHEMOPEXIN (HUMAN)HpxHx
02
Targets
Heme
Beyond the preview
Go deeper on hemopexin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hemopexin.